We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Silk Fibers Can Strengthen Bone Matrix Scaffolds

By HospiMedica International staff writers
Posted on 16 May 2012
A new silk-reinforced biodegradable material helps provide significant mechanical support during bone repair, according to a new study. More...


Developed by researchers at Tufts University (Boston, MA, USA), the micrometer-sized polymeric bone composite material is based on silk protein to protein interfacial bonding fibers that function as a reinforcement element for bone scaffold matrices, much as steel bars reinforce concrete in construction. The biodegradable composite, which mimics the mechanical properties of native bone, was created by fusing silk protein microfibers to a silk protein scaffold; the resulting material offers a high-compressive strength, and has been shown to support cell responses related to bone formation in vitro.

The researchers used alkaline hydrolysis to break down the complex silk molecules into their building blocks, reducing the time and cost of making the microfibers in a variety of sizes. The production time for 10 to 20 µm were fibers was obtained in just one minute, compared with production of 100 µm plus size fibers after 12 minutes of conventional processing. The researchers also found that matrix stiffness and surface roughness improved human mesenchymal stem cell (MSC) differentiation, when compared to silk sponges that were used as a control. The study was published early online on April 30, 2012, in the Proceedings of the National Academy of Sciences of the USA (PNAS). 

“By adding the microfibers to the silk scaffolds, we get stronger mechanical properties as well as better bone formation; both structure and function are improved,” said study coauthor David Kaplan, PhD, chair of biomedical engineering at Tufts University. “This approach could be used for many other tissue systems where control of mechanical properties is useful and has broad applications for regenerative medicine.”


Related Links:
Tufts University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.